Loading stock data…
$119.83-1.89 (-1.55%)
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions.
Haemonetics Corporation in the Healthcare sector is trading at $119.83 with a market capitalization of $4.8B. Wall Street consensus targets $122.20 (10 analysts), implying a +2.0% move over the next 12 months. The stock is currently near its 52-week high of $123.77, remaining 56.9% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $339.38M↓ | $346.35M↑ | $338.97M↑ | $327.31M↑ | $321.39M |
| Gross Profit | $202.80M↑ | $198.21M↓ | $202.39M↑ | $194.74M↑ | $192.24M |
| Operating Income | $57.46M↑ | $52.34M↓ | $68.11M↑ | $67.08M↑ | $53.87M |
| Net Income | $33.01M↑ | -$20.15M↓ | $44.74M↑ | $38.68M↑ | $34.03M |
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collection systems, donor management so...